Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Synthetic Lethality

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5
Synthetic Lethality
Synthetic lethality as a tool to find effective combination therapies
René Bernards
Netherlands Cancer Inst., Amsterdam, Netherlands
from AACR Annual Meeting 2014 on April 9, 2014 11:00 AM-1:00 PM
Synthetic Lethality
  •  
  • Permission not
    granted for presentation
  •  
  •  
Targeting the DNA damage response
Christopher Lord
Inst. of Cancer Research, London, United Kingdom
from AACR Annual Meeting 2014 on April 9, 2014 11:00 AM-1:00 PM
Synthetic Lethality
Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53 null tumors
Brooke M Emerling
Weill Cornell Medical College, New York, NY, United States
from AACR Annual Meeting 2014 on April 9, 2014 11:00 AM-1:00 PM
Synthetic Lethality
Screening for triple negative breast cancer vulnerabilities
Judy Lieberman
Harvard Medical School, Boston, MA, United States
from AACR Annual Meeting 2014 on April 9, 2014 11:00 AM-1:00 PM
Synthetic Lethality
  •  
  • Permission not
    granted for presentation
  •  
  •  
Synthetic lethal approaches for the treatment of lung cancer
Trever G. Bivona
UCSF, San Francisco, CA, United States
from AACR Annual Meeting 2014 on April 9, 2014 11:00 AM-1:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5